Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: And some still think S&L is our enemy.... SGE

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

SGE1

Rank: President [?]

Points: 26670 [?]

Votes: 187 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: And some still think S&L is our enemy.... SGE - fatwollit

in response to

Re: And some still think S&L is our enemy.... SGE

fatwollit

posted on Jun 19, 2007 11:07AM

Agreed in most respects. The only supposition in your post that I have a problem with is that some few shareholders benefit more than others from the dividends. IMO, not possible. All shareholders benefit equally, each based on the size of the their investment and the risk they've assumed.

The divys. I don't like 'em and haven't from the first. iImean, it was nice to get some money, better there were far better potential uses.

Turley is a younger guy, probably with younger guy attitudes. Hopefully this will translate into a new, better attitude about issuing dividends. Like STOP!

And think of this, Turley has been put in the driver's seat of a company for him to build. Opportunity time! How to best use all this money to build a company.....? Though Pohl stated a policy re: divys going forward, there's a new sheriff in town. I strongly suspect and hope that the divy policy is dead. If not, the divys will probably be minimal in order to meet policy while not significantly draining available resources.